Genmab A/S: Investigational Rinatabart Sesutecan (Rina-S) Continues to Show Encouraging Antitumor Activity in Patients with Advanced Ovarian Cancer
Media ReleaseCOPENHAGEN, Denmark; March 17, 2025 Results from Phase 2 RAINFOLTM-01 trial (B1 cohort) showed that with a median on-study follow-up of 48 weeks, Rina-S 120 mg/m2 led to a confirmed objec ...
Kauppalehti12h
Investigational Rinatabart Sesutecan (Rina-S®) Continues to Show Encouraging Antitumor Activity in Patients with Advanced Ovarian Cancer
Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.
Press Trust of India on MSN10h
Telangana CM acknowledges debt burden, says state borrowed Rs 4,000 cr RBI loan to pay salaries
Hyderabad, March 17: Telangana Chief Minister A Revanth Reddy has said his government is facing a cash crunch due to the debt ...
Technology Networks4h
The Dawning of Multimodal Genetics
This article explores 6-base genome sequencing and how it is empowering researchers to expand their studies to include both genetic and epigenetic data.
Citizen Matters23h
Is your water safe to drink? A practical guide for Chennai residents
Poor sewage management, over-extraction, and high TDS levels worsened the water contamination in Chennai. Here is a guide to ...